Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dose‐dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma
Ray D. Page, Frederick P. Smith, George F. Geils, et al.
Cancer (2005) Vol. 104, Iss. 9, pp. 1956-1961
Open Access | Times Cited: 11

Showing 11 citing articles:

Bilingual patient navigator or healthcare interpreter: What’s the difference and why does it matter?
Ineke H.M. Crezee, Cynthia Roat
Cogent Medicine (2019) Vol. 6, Iss. 1, pp. 181087776-181087776
Open Access | Times Cited: 102
Adaptive Neoadjuvant Chemotherapy Guided by 18 F-FDG PET in Resectable Non–Small Cell Lung Cancers: The NEOSCAN Trial
Jamie E. Chaft, Mark Dunphy, Jarushka Naidoo, et al.
Journal of Thoracic Oncology (2015) Vol. 11, Iss. 4, pp. 537-544
Open Access | Times Cited: 45
Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms
David J. Stewart, G. Chiritescu, Simone Dahrouge, et al.
Cancer Treatment Reviews (2007) Vol. 33, Iss. 2, pp. 101-137
Closed Access | Times Cited: 49
<p>Morbidity and associated factors of depressive disorder in patients with lung cancer</p>
Yu Lee, Pao‐Yen Lin, Meng‐Chih Lin, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 7587-7596
Open Access | Times Cited: 21
<p>Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome</p>
Mohamed Ashour, Hanan E. Shafik
Cancer Management and Research (2019) Vol. Volume 11, pp. 6275-6284
Open Access | Times Cited: 20
Molecularly Tailored Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer: A Time for Excitement and Equipoise
Christopher G. Azzoli, Bernard J. Park, William Pao, et al.
Journal of Thoracic Oncology (2008) Vol. 3, Iss. 1, pp. 84-93
Open Access | Times Cited: 24
Pattern analysis of microtubule-polymerizing and -depolymerizing agent combinations as cancer chemotherapies
Shitanshu Uppal, Y. Li, E Wendt, et al.
International Journal of Oncology (2007)
Open Access | Times Cited: 12
Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy
William N. William, Fadlo R. Khuri, Frank V. Fossella, et al.
American Journal of Clinical Oncology (2010) Vol. 33, Iss. 2, pp. 148-152
Open Access | Times Cited: 10
Hematopoietic growth factors in lung cancer
Carlo Genova, Erika Rijavec, Francesco Grossi
Current Opinion in Oncology (2016) Vol. 28, Iss. 2, pp. 135-144
Closed Access | Times Cited: 7
The benefits of resistance training in breast cancer survivors: a focus on maintaining bone density
Ashley Artese, Emily Simonavice, Lynn B. Panton
Expert Review of Quality of Life in Cancer Care (2016) Vol. 1, Iss. 3, pp. 239-248
Closed Access | Times Cited: 1
2005 Faculty Bibliography of Publications
Marylouise Lindsey, Tim Mason
(2005)
Closed Access
Page 1

Scroll to top